Chemoinformaics analysis of 3-TRANS,9-CIS,12-CIS,15-CIS-OCTADECATETRAENOIC-ACID
| Molecular Weight | 442.728 | nRot | 4 |
| Heavy Atom Molecular Weight | 392.328 | nRig | 22 |
| Exact Molecular Weight | 442.381 | nRing | 4 |
| Solubility: LogS | -6.75 | nHRing | 0 |
| Solubility: LogP | 7.222 | No. of Aliphatic Rings | 4 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 82 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 85.0436 |
| nHD | 1 | BPOL | 51.0284 |
| QED | 0.444 |
| Synth | 4.754 |
| Natural Product Likeliness | 3.068 |
| NR-PPAR-gamma | 0.502 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0 |
| HIA | 0.011 |
| CACO-2 | -5.082 |
| MDCK | 0.0000089 |
| BBB | 0.213 |
| PPB | 1.00575 |
| VDSS | 0.936 |
| FU | 0.0183232 |
| CYP1A2-inh | 0.017 |
| CYP1A2-sub | 0.511 |
| CYP2c19-inh | 0.037 |
| CYP2c19-sub | 0.965 |
| CYP2c9-inh | 0.1 |
| CYP2c9-sub | 0.879 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.221 |
| CYP3a4-inh | 0.125 |
| CYP3a4-sub | 0.564 |
| CL | 16.107 |
| T12 | 0.03 |
| hERG | 0.005 |
| Ames | 0.022 |
| ROA | 0.184 |
| SkinSen | 0.021 |
| Carcinogencity | 0.04 |
| EI | 0.031 |
| Respiratory | 0.956 |
| NR-Aromatase | 0.597 |
| Antiviral | No |
| Prediction | 0.658468 |